ASCO 2023 news drops ahead of June meeting: Merck, BMS, Regeneron, and more
Slump in medtech VC activity continues as inflation keeps investors on the sidelines
Noom to offer prescriptions for weight-loss drugs
ASCO puts spotlight on advancing antibody-drug conjugate pipeline
*please scroll down for all the latest news*
